Details

NameSymbolSector
AAREY DRUGS & PHARMACEUTICALS LTDAAREYDRUGSPharmaceuticals
Open
98.47
High
99.2
Low
94.21
Close
98.03
Volume
142520
Exchange
nse
Time
08-Sep-2026

Outlook

Score:

1.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofAareyDrugs&Pharmaceuticalsis
High Wave
EstimatedStoplossofAareyDrugs&Pharmaceuticalsis
99.2
AareyDrugs&Pharmaceuticalshasa
Bearishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofAareyDrugs&Pharmaceuticalsis
Unpredictableℹ
.

Trend

AareyDrugs&Pharmaceuticalsisin
Uptrendℹ
.
PriceofAareyDrugs&Pharmaceuticalsis
Upℹ
by

16.07

%.
Target
Buy@

77.4

Sell@

98.5

Current@

98.03

Volume

ThetradesofAareyDrugs&Pharmaceuticalshavebeenin
Immenseℹ
volume.
ThevolumetradesforAareyDrugs&Pharmaceuticalsare
Bullishℹ
with
Strong Buyersℹ
ThetradevolumeofAareyDrugs&Pharmaceuticalsis

Up

by

60.81

%

Valuation

ThecurrentmarketpriceofAareyDrugs&Pharmaceuticalsis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth290crandtotalassetsworth290cr,thebalancesheetofAareyDrugs&Pharmaceuticalsis:
Balancedℹ
.
Cashflow
AareyDrugs&Pharmaceuticalshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
52.63% i.e. ₹ 10cr earned in operatingℹ
26.32% i.e. ₹ 5cr spent in investingℹ
21.05% i.e. ₹ 4cr spent in financingℹ
0% in otherℹ
AareyDrugs&Pharmaceuticalshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
25% i.e. ₹ 2cr spent in operatingℹ
12.5% i.e. ₹ 1cr spent in investingℹ
62.5% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofAareyDrugs&Pharmaceuticalsis

₹ 84cr

and

Profit

is:

₹ 1cr

AareyDrugs&PharmaceuticalsProfitisupby:

0

%andIncomeisDownby:

18.45

%
TheincomeofAareyDrugs&Pharmaceuticalsis

₹ 103cr

and

Profit

is:

₹ 1cr

AareyDrugs&PharmaceuticalsProfitisupby:

100

%andIncomeisDownby:

10.43

%
TheincomeofAareyDrugs&Pharmaceuticalsis

₹ 115cr

and

Loss

is:

₹ 0cr

AareyDrugs&PharmaceuticalsLossesincreasedby:

0

%andIncomeisDownby:

14.18

%
By using this site you agree to the use of cookies to deliver a better site experience.